Answers are grounded in this paper and cite their sources.
The FINESSE provides recommendations for trial design in SVD for which there are currently few effective treatments. However, new insights into understanding disease pathogenesis, particularly from recent genetic studies, provide novel pathways that could be therapeutically targeted. In addition, whether other currently available cardiovascular interventions are specifically effective in SVD, as opposed to other subtypes of stroke, remains uncertain. FINESSE provides a framework for design of trials examining such therapeutic approaches.
No takes yet. Share an insight, caveat, or question.
Markus et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: